NCDA News



The NCDA publishes e-newsletters monthly, filled with the latest legislative and clinical news that impacts the dermatology profession. Want to receive the NCDA News? Email us and let us know.


Seeking Candidates for MF and Alopecia Studies

NCDA Member Dr. Elise Olsen at Duke University is the Principle Investigator on a multicenter trial sponsored by Galderma of a new topical imidazoquinoline called resiquimod (CD11301). This is a randomized, double-blind, placebo-controlled, phase 2 trial to assess the safety, efficacy and pharmacokinetics of CD11301 0.03% and 0.06% gel in the treatment of Cutaneous T-Cell Lymphoma (CTCL), stages IA, IB and IIA. Patients must have a firm diagnosis of mycosis fungoides (MF) type of CTCL and must be willing to wash out of any treatment they are currently on for MF prior to receiving study drug. Not all lesions will be treated since there is data to suggest a remote effect on lesions: however, the % of lesions treated with study drug will be increased after 14 weeks and those on placebo initially will receive active drug beginning at 12 weeks as well. If you have a patient that may be a good candidate for the study or any questions about the study, please contact the Duke Dermatopharmacology research office directly at 919-668-5610.

Dr. Olsen is also the Principle Investigator on a multicenter trial sponsored by Aclaris Therapeutics, Inc. of a new topical JAK inhibitor for alopecia areata. The study aims to assess the safety, tolerability, and efficacy of two different doses of the topical study drug ATI-50002 compared to vehicle in subjects with stable patchy alopecia areata. We are seeking subjects 18 years of age or older who have a clinical diagnosis of alopecia areata with 15% to 95% total scalp hair loss and a current episode of continued hair loss for greater than 6 months but less than 12 years. This is a second notice since the study has been amended to allow a greater number of patients to enter. If you have a patient that may be a good candidate for the study, please either contact the Duke Dermatopharmacology research office directly or have your patient contact the research office at 919-668-5610.



2018 AADA Legislative Conference Wrap Up

A 5-person delegation of dermatology providers and patient-advocates from North Carolina participated in the 2018 AADA Legislative Conference July 15-17 in Washington, DC. The AADA Legislative Conference offers dermatologists from around the country the unique opportunity to receive advocacy training taught by health policy experts and to spend a day meeting with their members of Congress and their staff on Capitol Hill to talk about the most pressing issues facing the specialty and dermatology patients. The key issues addressed at this year’s meeting included:

Thank you, 2018 Legislative Conference Participants!

  • Robin Inabinet, RN-BC, Dermatology Nurses' Association (Clemmons)
  • Jodie Ohr, International Topical Steroid Addiction Network (Huntersville)
  • Jeffrey W. Weisgerber, International Pemphigus & Pemphigoid Foundation (Nags Head)
  • Linda Markham, RN, Dermatology Nurses' Association (Vass)
  • W. Alan Skipper, CAE, NC Dermatology Association (Raleigh)


Thank You, Skin Screening Volunteers!

The NCDA's Annual Skin Screening Day at the Legislature, held on June 6, was a terrific success thanks to the nine dermatologists and dermatology PAs who volunteered their time and talents. The event was held at the legislative building in Raleigh. Eighty-two North Carolinians were screened for suspicious lesions and moles and took home a goodie bags of skin care products.

Please join us in thanking this year's volunteers!

  • Peter Mattei, MD / Pinehurst
  • Russell J. Kilpatrick, MD / Greenville
  • Christopher Henderson, MD / Durham
  • Susan Sanders, MD / Concord
  • Adam Ingraffea, MD / Cary
  • Sarah Wolfe, MD / Chapel Hill
  • Betty Jiang, MD / Durham
  • Lisa Christman, MD / Raleigh
  • Leighanne McGill, PA-C / Chapel Hill


NCDA Recognized by AADA with Model State Award

The NCDA is proud to announce that we brought home some exciting new hardware from the 2018 American Academy of Dermatology Annual Meeting in San Diego, CA. The NCDA was recognized by the Academy with the 2017 Model State Award. Model State Award recipients receive a development grant from the Academy. In order to qualify for the Model State Award, societies must meet the specified core criteria in addition to several operational criteria, such as involvement in legislative and regulatory advocacy, member engagement and educational initiatives.

As the state's only professional association dedicated to representing our specialty and promoting excellence in patient care, our number one goal is to support dermatologists and dermatology physician assistants in North Carolina, which we do through education, communications, advocacy and professional relations. In 2017, we presented two excellent educational conferences, provided ongoing public education about the dangers of UV exposure, engaged in payer issues, raised charitable funds and awareness for Victory Junction, and hosted another successful Annual Skin Cancer Screening at the Legislature with the support of volunteers from across the state.

The NCDA appreciates this special recognition, which is thanks to the strong support and participation of our NCDA members. Thank you for supporting the NCDA!



Representative Greg Murphy Featured in NC Health News

NC Representative Greg Murphy, MD, a Greenville urologist and the only physician serving in the NC General Assembly, credits his years of medical training for imparting the discipline and stamina necessary to be successful as a legislator in Raleigh. And that he is! As a new legislator, Dr. Murphy has been tapped for some very important posts, including a Vice Chair seat on the Appropriations Committee (arguably the most important committee in the House), Chair on the Appropriations Health and Human Services Committee and Chair on the Health Committee.

Dr. Murphy was recently featured by the online news site North Carolina Health News.


ACO Guide for Dermatologists

Specialty-specific toolkits, like the "Accountable Care Guide for Dermatologists," from the NCMS Toward Accountable Care Consortium and Initiative (TAC) can help your practice make the transition from fee-for-service to value-based health care. The toolkit provides strategic guidance for physicians establishing and participating in accountable care organizations (ACOs) and it is part of a series offering guidance on a range of topics related to the legal and financial issues that you need to know about.

NEW! Want CME credit for learning more about ACOs?The Texas Medical Association was so impressed with the NCMS TAC toolkits, they sought and received permission to offer CME credit for reading and absorbing the information in the seminal guide, "The Physicians Accountable Care Toolkit." If you are an NCMS member, you can access this CME at a discount by simply downloading the guide and entering "NCMS" in the coupon code space to receive the member discount.

All TAC toolkits are available free of charge from the TAC website, www.tac-consortium.org. Additional titles include "Accountable Care Legal Guide, " "The Bundled Payment Guide for Physicians, " "Rural Accountable Care Guide," and more.



NCDA-backed Legislative Priority Becomes State Law


Prom is now a whole a lot healthier, thanks to the NCDA's leadership and support of the Jim Fulghum Teen Skin Cancer Prevention Act. The NCDA-backed legislation achieved its final hurdle on May 21, 2015 when N.C. Governor Pat McCrory signed the bill into law. The new law, which took effect on October 1, 2015, prohibits tanning facilities from allowing minors under the age of 18 to use indoor tanning equipment. Governor McCrory signed the hard-won Jim Fulghum Teen Skin Cancer Prevention Act into law at the Executive Mansion with the late Rep. Fulghum's wife Mary Susan, and his daughter, son-in-law and granddaughter at the Governor's side.

"This law will save lives and significantly help protect children and young adults from the growing epidemic of skin cancer," said NCDA President Russell Kilpatrick, MD. "We thank our legislators and the governor for their support and action on this important health issue."

For all of the latest NCDA news, be sure to check out our latest newsletter.